ArticleTurkish archives of pediatrics2025
Adverse Event Profiles of Acetaminophen and Ibuprofen in Infants: A Food and Drug Administration Adverse Event Reporting System Database Retrospective Cohort Study.
Article in Turkish archives of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to analyze adverse events (AEs) associated with the use of acetaminophen and ibuprofen in infants based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database. The study also seeks to evaluate the safety differences between these 2 drugs to provide scientific evidence for clinical practice. Materials and Methods: This study utilized the FAERS database and employed 3 statistical methods: Proportional Reporting Ratio, Reporting Odds Ratio, and Bayesian Confidence Propagation Neural Network to identify AEs signals associated with acetaminophen and ibuprofen. The positive AEs signals were classified according to the System Organ Class (SOC) to assess the relationship between Preferred Term signals and their corresponding SOCs. Results: The total number of reported AEs associated with acetaminophen and ibuprofen was 2102 and 691, respectively. Further comparison showed that acetaminophen was associated with significantly higher incidences of hepatobiliary disorders (P < .001, OR: 2.61, 95% CI [1.48, 4.59]) and nervous system disorders (P = .009, OR: 3.14, 95% CI [1.27, 7.71]) compared to ibuprofen. However, acetaminophen had a significantly lower risk of "general disorders and administration site conditions" (P < .001, OR: 0.13, 95% CI [0.07, 0.27]) and "renal and urinary disorders" (P < .001, OR: 0.19, 95% CI [0.09, 0.41]) compared to ibuprofen. Conclusion: Through a systematic analysis of the FAERS database, this study highlights significant safety differences between acetaminophen and ibuprofen. The findings offer direct guidance for clinicians in selecting safer antipyretic medications, supporting optimized fever management practices and minimizing drug-related AEs in infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.